Paradigm Biopharmaceuticals Ltd (ASX:PAR) has completed a $14 million placement and launched a share purchase plan (SPP) to raise up…
Read More

Paradigm Biopharmaceuticals Ltd (ASX:PAR) has completed a $14 million placement and launched a share purchase plan (SPP) to raise up…
Read More
Though Magellan has ultimately received the go ahead for its planned merger with Barrenjoey, the firm is facing some backlash…
Read More
FireFly Metals Ltd (ASX:FFM, TSX:FFM, OTC:MNXMF) has locked in commitments to raise about A$134.1 million and is seeking a further…
Read More